Graftys

Graftys, taken over in 2017 by Enrico Bastianelli (ex-CEO of Bone Therapeutics), active in medtech’s market, is one of the world leaders (alongside BONESUPPORT AB, listed on the NASDAQ in Stockholm), in synthetic resorbable orthopaedic cements, with a pipeline of 2 marketed products (registered in 27 countries).

Following to the capital increase structured by TheClubDeal, Graftys has relocated its headquarters in Wallonia from France while refocusing its French unit (located in Aix-en-Provence) around its core cement production skills. A new R&D unit in Nantes will be opened as well.

Website: https://www.graftys.com

Category:

Medical Technologies

Investment:

4100000

Deal Status:

Invested

Investment Type:

Scale Up